Home -> Law Blog Directory -> Legal News Blogs -> Lawyers and Settlements
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Legal News
: Lawyers and SettlementsResearcher Reprimanded for Ties to GlaxoSmithKline
ADVERTISEMENTS
Atlanta, GA: While pregnant women have to sift through the conflicting evidence regarding Paxil birth defects to determine whether or not the risk of reported Paxil side effects outweighs the benefits, news has emerged that at least 1 researcher had ties to GlaxoSmithKline, maker of Paxil, while he was conducting research about the drug. Although financial ties to the pharmaceutical industry are not uncommon for researchers, such a relationship can call into question the unbiased nature of research that is performed, especially when that research shows the positives of the drug involved.Full post as published by Lawyers and Settlements on June 28, 2009 (boomark / email).
Related Law Articles
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
Lawsuits and Settlements
GlaxoSmithKline Pays $750 Million Over Defective Drugs
GlaxoSmithKline Pays $750 Million Over Defective Drugs
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

GlaxoSmithKline to Acquire Sirtris Pharmaceuticals; Solvay Tenders Offer for Innogenetics
GlaxoSmithKline Escapes Criminal Prosecution
Judge reprimanded for ‘extraordinary’ response in court to job rejection
New opinion on collateral estoppel in class action cases: Johnson v. GlaxoSmithKline, Inc.
GlaxoSmithKline CEO Calls For Patent Pool








